International Journal of Women's Health and Reproduction Sciences

Home Aim and Scope Instructions to Authors Editorial Policies Editorial Board Authorship Agreement Form Open Access and Copyright

Jan 2022, Vol 10, Issue 1

CURRENT ISSUE ARCHIVE AHEAD OF PRINT / ACCEPTED ARTICLE MOST VIEWED ARTICLES NEWS RELATED LINKS

Advanced Search

For Author's & Reviewer's

Committee on Publication
Ethics (COPE) Flowchart

Recommendations for the Conduct

COPE: Reviewers

World Association of Medical Editors(WAME)

EQUATOR Resources : Reviewers

Poll

How do you find the scientific quality of the published articles on our web site?

Very good

Good

Fair

Bad

Very bad

Original Article
Efficacy of the Intrauterine Infusion of Platelet-Rich Plasma on Pregnancy Outcomes in Patients With Repeated Implantation Failure: A Randomized Control Trial
Leili Safdarian¹, Ashraf Aleyasin¹, Marzieh Aghahoseini¹, Parvaneh Lak¹, Sedigheh Hoseini Mosa¹, Fatemeh Sarvi¹, Atossa Mahdavi¹, Aida Najafian¹, Parvin Falahi¹, Salman Khazaei²
¹Department of Obstetrics and Gynecology, School of Medicine, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran ²Research Center for Health Sciences, Hamadan University of Medical Sciences, Hamadan, Iran
IJWHR 2022; 10: 038-044 DOI: 10.15296/ijwhr.2022.08 Viewed : 2617 times Downloaded : 2239 times. Keywords : Repeated implantation failure, Platelet-rich plasma, Clinical pregnancy, In vitro fertilization
Full Text(PDF) \| Related Articles
Abstract

Objectives: The aim of the present study was to evaluate the effect of the intrauterine administration of platelet-rich plasma (PRP) before embryo transfer (ET) on pregnancy outcomes in women with repeated implantation failure (RIF). Materials and Methods: This randomized controlled trial included 120 RIF women who were candidates for frozen-thawed ET. In the PRP group (n = 60), the intrauterine infusion of 0.5 mL PRP was performed 48 hours before ET, and the control group (n=60) underwent ET without intrauterine administration. Results: The implantation rate (28% vs. 11.9%, P < 0.001), clinical pregnancy (51.6% vs. 26.6%, P = 0.005), and live birth rate (58.3% vs. 28.3%, P = 0.001) in PRP group were significantly higher compared to the control group. Based on the results, there was no significant difference with regard to miscarriage (12.5% vs. 12.9%, P = 0.97) and multiple pregnancy rate (0.133% vs. 0.05%, P = 0.11) between the two groups. Finally, preterm delivery was significantly higher in the PRP group (P < 0.001). Conclusions: According to this study, the result revealed that PRP is effective in the improvement of pregnancy outcomes in RIF patients. Further studies are needed to identify the group of patients who would benefit from this intervention.